Five drug approvals to watch in 2026 These late-stage therapies span obesity, diabetes, hypertension, and allergy care, offering new mechanisms and delivery formats that could reshape patient treatment.

https://www.drugdiscoverynews.com/five-drug-approvals-to-watch-in-2026-16982?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_tFN88dAIbLCv9kT2L5vEoNEwvW15zK9GNn4176MSmvT8ho6_7gyP-JCBqff-ZQIF5sk4IScdWOwYVET-Z03m0SfDRWQ&_hsmi=405284917&utm_content=405284917&utm_source=hs_email During 2025, the FDA approved several notable new drugs and vaccines — from a novel eye drop treatment to the first new oral antibiotic class for uncomplicated urinary tract infections in decades. And looking ahead to 2026, there are several other innovative ‘firsts’ on the way that could reshape how patients manage everything from allergic reactions to diabetes and hypertension.